Skip to main content
Erschienen in: BMC Women's Health 1/2021

Open Access 01.12.2021 | Research article

Factors associated with delay in seeking treatment among women with pelvic organ prolapse at selected general and referral hospitals of Southern Ethiopia, 2020

verfasst von: Asfaw Borsamo, Mohammed Oumer, Yared Asmare, Ayanaw Worku

Erschienen in: BMC Women's Health | Ausgabe 1/2021

Abstract

Background

Pelvic organ prolapse (POP) is the descent of the vaginal wall, cervix, uterus, bladder, and rectum downward into the vaginal canal. Its prevalence is higher among women in developing countries because women are more prone to risk factors. In Ethiopia, women with prolapse seek treatments at advanced stages of prolapse; hence, surgical management has been widely practicing. Therefore, it was found to be very important to conduct research that assesses factors hindering early treatments in Southern Ethiopia. This study aimed to find out factors associated with the delay in seeking treatment of pelvic organ prolapse among patients at selected general and referral hospitals of Southern Ethiopia.

Methods

Cross-sectional study design was employed in 123 participants of seven randomly selected General and Referral Hospitals of Southern Ethiopia from February 01 to April 30, 2020, by using a structured questionnaire. Pre-trained two midwives in each center were deployed to collect data. Physicians performed diagnosis and physical examination. Data were entered and coded using EPI INFO version 7 and exported into SPSS version 25 for analysis. Bivariate and multivariable logistic regression analyses were performed. The goodness of fit was assessed by using the Hosmer and Lemeshow goodness test.

Results

In this study, out of 123 clinically diagnosed POP cases, nearly half of them were stage III, and over one-third were stage IV. Therefore, 84.6% (104 participants) of the respondents were delayed for the treatment of POP. The mean length of delay for POP treatments was 36.41 ± 3.95 months. After adjusting for covariates, lack of supports [AOR (Adjusted Odds Ratio) = 5.2 (95% CI 1.4–19.5)], low-income [AOR = 5.8 (95% CI 1.1–19.66)], and fear of social stigma [AOR = 4.7 (95% CI 1.2–18.59)] were significant factors for delayed treatments.

Conclusions

Most of the POP patients were delayed for POP treatments. Factors like lack of support, low-income, and fear of losing social value/stigma were associated with treatment delay. Screening for the POP cases, educating (making awareness) the community about this devastating disease to facilitate early treatment and to avoid social stigma, and raising access to treatment by making the nearby hospitals equipped with facilities to treat POP are recommended.
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
AOR
Adjusted odds ratios
COR
Crude odds ratios
POP
Pelvic organ prolapse
SNNPR
South Nations Nationalities and Peoples’ Region

Background

Pelvic organ prolapse (POP) is the herniation of the uterus, the cervix, the vaginal wall, the bladder, and the rectum downward along the vaginal lumen [1]. It is a common gynecological problem, which is more prevalent in developing countries, that affect the life quality of women by limiting emotional, physical, psychosocial, and sexual functions [2, 3].
The prevalence of POP varies widely from population to population depending on the level of exposure to the risk, level of awareness about POP, and level of the socio-economic status. Universally, the prevalence of this problem is about 3.5% to 15% when it is studied by defining symptoms and it reaches up to 64.6% when studied based on objective findings, which are directly measured by the experts [38].
Women in the developed countries who have access to modern health care can benefit from the advances that have been made in treating POP. Moreover, women in developed nations have an awareness of the problem, high literacy rate, and high-income level with excellent health facilities that can screen the POP very early. Delaying for treatment is also affected by high parity, little or no access to health care, and the presence of problems associated with POP [9].
The prevalence of POP in Africa varies widely from country to country: 64.6% in Tanzania [5], 19.4% in Egypt [10], and 6.5% in Nigeria [11]. The prevalence of the POP in Ethiopia is also highly variable ranging from 1 to 56.4% [3, 7, 12]. For instance, 40.7% among gynecologic case in Jimma Hospitals [13], 15% among gynecologic case in Saint Paulos Hospital, Addis Abeba [14], 56.4% in Dabat community, Gondar [3], 20.9% in Kersa community, Ethiopia [7], and 13.3% in Benchi Maji Zone [15].
Essentially, delaying the POP treatments worsens the problem further in Ethiopia. Many women are silent victims of uterovaginal prolapse, hiding the problem owing to fearing social stigma. Despite uterovaginal prolapse is a matter of discomfort for women, it affects many aspects of their daily life [12, 16]. According to a community-based objectively measured study at Dabat district, Gondar, the prevalence of POP is about 56.4%, however, only patients with advanced stages of POP (3.2%) visited the hospitals, even if free service is providing [3].
According to few studies assessing reasons for delayed treatments among women within Ethiopia, the possible reasons are lack of support, low awareness, low literacy, unavailability of the treatment center, low income, and disclosure of the problem or fear of social stigma [12, 16]. In Ethiopia, although the non-governmental organizations in collaboration with the Federal Ministry of Health tried to deliver free services for the victims integrating with obstetric fistula care, the women kept home hiding their problems even from their close partners. This indicates that little attention is given to health education, and creating awareness on the problem. Besides, few studies were conducted on reasons hindering early treatment [12, 16].
There is a scarcity of the study assessing factors associated with the delay in seeking treatment among women with POP in Southern Ethiopia. Notably, exposing factors that hinder early treatments of POP initiates up responsible bodies to take interventional actions at the early stages of the problem. Therefore, it was found to be very important to conduct research that assesses factors associated with the delay in seeking treatment among women with POP in South Nations Nationalities and Peoples’ Region (SNNPR).

Methods

Study design and setting

The hospital-based cross-sectional study design was conducted from February 01 to April 30, 2020, in seven (out of thirteen hospitals) randomly selected governmental general and referral hospitals of southern Ethiopia. All gynecologic patients diagnosed with a POP at selected governmental general and referral hospitals of Southern Ethiopia were included in the study. A total of 123 eligible POP women participated in the study.

Measurement

POP was evaluated and described using a standardized Pelvic Organ Prolapse Quantitative Examination Tool. In this technique, the hymen ring (remnant) is considered as a reference point [1, 17]. The stages of POP were presented in Table 1.
Table 1
The pelvic organ prolapse staging, 2020
Stages
Description
0
No prolapse [1, 17]
I
The leading-edge of the prolapse is 1 cm above the level of the hymen (> − 1 cm) [1, 17]
II
The leading-edge of the prolapse lies through the plane of hymen between − 1 cm and + 1 cm [1, 17]
III
The most distal portion of the prolapse is between + 1 cm and + 2 cm below hymen [1, 17]
IV
The complete eversion of the total length of the pelvic organ (> + 2 cm)

Operational definitions

Delayed treatment of POP: Advanced stage prolapses treated with surgical management regardless of the duration of the onset of symptoms [1]. Early treatment of POP: Early-stage prolapses treated with conservative management regardless of the duration of the onset of symptoms [1]. Low income: Those who earn less than 1200 Birr monthly were considered as low income and, practically, those women who have the interest to go hospital but delay in seeking treatment due to the lack of money [12, 18]. Lack of support: Those women who delayed in seeking treatments because they do not have a person who supports them financially and emotionally [12, 16]. Culture influence: In some cultures in Ethiopia, it is extremely shameful exposing, discussing, and talking about anything related to genitalia (sensitive body parts), even to their daughters and children [12]. Being busy: Those women who delayed in seeking treatments because they are busy with works and with different responsibilities [19]. Fear of social stigma: A woman with POP who delayed in seeking treatments due to the high concern of social discrimination [11, 12].

Data collection tools, techniques, and procedures

Data were collected using the interviewer-guided structured questionnaire, having two parts: The first part assessed objective findings, and the second part assessed factors for delayed treatments. To assess objective findings, physicians first took the surgical and medical history of the patients. Then, they performed vaginal examinations and diagnoses. Based on Standardized Pelvic Organ Prolapse Quantitative Examination Tool, physicians determined the stages of POP. After the physician decided on management, participants were interviewed.
The questionnaire was developed by the investigators by reviewing different related literature [3, 11, 12, 16, 20]. Then, the questionnaire was evaluated by the experts in the profession to ensure validity. The questionnaire was first prepared in English, and, then, appropriately translated into the Amharic language. Later, translated back to English to ensure the accuracy of the meaning. A pretest was carried out on 10% of the sample size at the Shashemene General Hospital, Oromia, Ethiopia, and Bushulo General Hospital, Sidama, Ethiopia (private obstetrics and gynecology center) mainly to check the general approachability, validity, and feasibility of the questionnaire. As a result, corrections and modifications were made to the questionnaire accordingly. Two midwives collected the data using the Amharic version questionnaire under strict supervision.

Data quality control and management

Data quality was controlled through the provision of one-day training to the data collectors about the overall objective of the study, the definition of terms and concepts, approaching of respondents, data collection tools, and techniques of interviewing. The collected data were also cross-checked for its completeness, consistency, accuracy, and clarity daily. The investigators carried out close site supervision during the whole data collection period to monitor overall data collection quality.

Data processing and analysis

After data collection, each questionnaire was again visually checked for completeness, clarity, and accuracy. Data were coded and entered into EPI INFO version 7 software and exported to SPSS version 25 statistical software for analysis. Descriptive, bivariate, and multivariable logistic regression analyses were performed. Selected variables that have a P value of ≤ 0.2 at the bivariate logistic regression analysis were included in the multivariable logistic regression to control all possible confounding factors simultaneously. The goodness of fit was assessed by using the Hosmer and Lemeshow goodness test. Generally, a P value ≤ of 0.05 was considered statistically significant.

Results

Socio-demographic characteristics of the participants

Out of 123 participants, the majority (61%) were aged ≥ 45 years. Over two-thirds (67.48%) of the participants did not attend formal school at all. About 66.70% of participants were rural residents and 71.54% were housewives. The majority (69.01%) earns ≤ 1200 Ethiopian birrs monthly (Table 2).
Table 2
Sociodemographic characteristics of the participants at selected general and referral hospitals of Southern Ethiopia, 2020
Variables
Frequency (n = 123)
Percent (%)
Age
  
 ≤ 35
13
10.57
 34–44
35
28.46
 ≥ 45
75
60.97
Ethnicity
  
 Wolaita
33
26.83
 Sidama
27
21.95
 Gurage
16
13.00
 Hadiya
14
11.38
 Amhara
8
6.50
 Oromo
8
6.50
 Kambata
7
5.70
 Gamo
6
4.88
 Dorze
2
1.63
 Amaro
1
0.81
 Halaba
1
0.81
Religion
  
 Protestant
68
55.28
 Orthodox
43
34.96
 Muslim
9
7.32
 Waka and traditional believers
7
5.69
Residency
  
 Rural
82
66.70
 Urban
41
33.30
Occupational status
  
 House wife
88
71.54
 Farmer
23
18.70
 Merchant
23
18.70
 Employed
24
19.51
Educational status
  
 No schooling
83
67.48
 Primary
18
14.63
 Secondary
15
12.20
 Diploma +
7
5.69
Marital status
  
 Married
104
84.55
 Widowed
10
8.13
 Divorced
9
7.32
Monthly income (ETB)
  
 > 1200
38
30.89
 ≤ 1200
85
69.01

Description of delayed treatments

One hundred twenty-three cases were clinically diagnosed for POP. Out of 123 POP cases, nearly half (60 participants) of them were stage III, and over one-third (44 participants) were stage IV. Therefore, 84.6% (104 participants) of the respondents were delayed for the treatment of POP. The mean length of delay for POP treatments was 36.41 ± 3.95 months (Table 3).
Table 3
Summary of stages of POP and management types at selected General and Referral Hospitals of Southern Ethiopia, 2020
Stage of POP
Frequency
Percentage (%)
Stage I
0
0
Stage II
19
15.4
Stage III
60
48.8
Stage IV
44
35.8
Management types
  
Surgically managed
104
84.6
Conservatively managed
19
15.4

Reasons for delayed treatments

Out of 123 women with POP, 58.54% of women complained of a lack of support as the reason for the delayed treatments. The majority (73.17%) reasoned out a lack of transportation for delayed treatments (Table 4).
Table 4
Reasons for delayed POP treatments among participants at selected General and Referral Hospitals of Southern Ethiopia, 2020
Variables
Delayed treatment (n = 104)
Early treatment (n = 19)
Total (n = 123)
Percent (%)
Lack of support
    
 No
38
13
51
41.46
 Yes
66
6
72
58.54
Low income
    
 No
49
15
64
52.03
 Yes
55
4
59
47.97
Lack of transportation
    
 No
19
14
33
26.83
 Yes
85
5
90
73.17
Unavailability of treatment centers
    
 No
75
16
91
78.98
 Yes
29
3
32
21.02
Believing POP as normal
    
 No
70
18
88
71.54
 Yes
34
1
35
28.46
Fear of surgery
    
 No
53
12
65
52.84
 Yes
51
7
58
47.16
Culture influence
    
 No
58
13
71
57.72
 Yes
46
6
52
42.18
Fear of stigma
    
 No
40
14
54
43.90
 Yes
64
5
69
46.10
Fear of disclosure
    
 No
42
14
56
45.53
 Yes
62
5
67
54.47
Being busy
    
 No
62
11
73
59.34
 Yes
42
8
50
40.66

Factors associated with delayed treatments

On bivariate logistic regression analysis, lack of support, low-income, lack of transportation and road, believing POP as normal, fear of losing social value/stigma, fear of disclosure, maternal age, and educational status were significant reasons for delayed treatments. On multivariable logistic regression analysis, lack of support, low-income, and fear of losing social value/stigma were reasons associated with delayed treatments of POP patients. Accordingly, women with a lack of support were five times [AOR = 5.2 (95% CI 1.42–19.5)] more likely to delay treatments of POP than their counterparts. Women with low-income were nearly six times [AOR = 5.8 (95% CI 1.1–19.66)] more likely to delay treatments of POP than women with higher income. Women who fear social stigma was about nearly five times [AOR = 4.7 (95% CI 1.2–18.59)] more likely to delay treatments as compared to their counterparts (Table 5). The value of the Hosmer and Lemeshow goodness of fit test was 0.332.
Table 5
Logistic regression analysis about factors associated with the delay in seeking treatment of POP patients at selected general and referral Hospitals of Southern Ethiopia, 2020
Variables
Delayed treatments
Early treatment
COR(95%CI)
AOR (95%CI)
Lack of support
    
 No
38 (74.5%)
13 (25.5%)
1
1
 Yes
66 (91.7%)
6 (8.3%)
5.2 (2.0–15.36)
5.2 (1.42–19.5)*
Low income
    
 No
49 (76.6%)
15 (23.4%)
1
1
 Yes
55 (93.2%)
4 (6.8%)
4.2 (1.3–13.54)
5.8 (1.1–19.66)*
Lack of transportation
    
 No
19 (57.6%)
14 (42.4%)
1
1
 Yes
85 (94.4%)
5 (5.6%)
8 (2.628–24.26)
2.2 (0.56–8.48)
Unavailability of treatment centers
    
 No
75 (82.45)
16 (17.6%)
1
 
 Yes
29 (90.6%)
3 (9.4%)
2.06 (0.56–7.6)
Believing POP as normal
    
 No
70 (79.5%)
18 (20.5%)
1
1
 Yes
34 (97.1)
1 (2.9%)
8.74 (1.12–68.2)
9.9 (0.96–11.3)
Fear of surgery
    
 No
53 (81.5%)
12 (18.5%)
1
1
 Yes
51 (87.9%)
7 (12.1%)
1.65 (0.6–4.52)
Culture influence
    
 No
58 (81.7%)
13 (18.3%)
1
 
 Yes
46 (88.5%)
6 (11.5%)
1.7 (0.61–4.87)
Fear of social stigma
    
 No
40 (74.1%)
14 (25.9%)
1
1
 Yes
64 (92.8)
5 (7.2%)
4.48 (1.5–13.39)
4.7 (1.2–18.59)*
Fear of disclosure
    
 No
42 (75%)
14 (25%)
1
1
 Yes
62 (92.5%)
5 (7.5%)
4.1 (1.4–12.34)
4 (0.99–16.43)
Being busy
    
 No
62 (84.9%)
11 (15.1%)
1
 
 Yes
42 (84%)
8 (16%)
0.93 (0.35–2.51)
Key: AOR, adjusted odds ratios; COR, crude odds ratios
*Statistically significant at P value ≤ 0.05 in multivariable logistic regression analysis

Discussion

This study primarily assessed factors associated with the delay in seeking treatment among women with POP at selected general and referral hospitals of Southern Ethiopia. Accordingly, lack of support, low income, and fear of social stigma were significant factors associated with delayed treatments of POP patients. This study also assessed reasons for delayed treatments among POP patients at selected general and referral hospitals of Southern Ethiopia. Out of 123 POP patients, only 15.4% of POP patients came with earlier stages of POP. The mean length of delay for POP treatments was 36.41 ± 3.95 months. This finding is comparable with the study finding of Israel (43 months) [21]. Nevertheless, it is lower when compared with the mean length of delay in the study conducted in Gondar (85.8 ± 80.2 months) [12]. The most likely justification for this discrepancy is that in our study the patients with POP visited the hospital for seeking treatments by themselves. Meanwhile, in the Gondar study, there was a community-based screening and campaign for searching the cases of POP and, in this case, a lot of cases of POP may surveyed for the treatments and several cases with longer duration may contribute to the high value of estimates because in the community we can find a woman who stayed for longer period by hiding the problem.
This study revealed women with a lack of support were over five times more likely to delay treatments of POP than their counterparts. This is inconsistent with the report from the study of Gondar saying lack of support is not associated with delaying for the treatments [12]. The possible justification for this discrepancy is most probably the POP care in Gondar is integrated into the fistula care center. In Gondar, women with POP are free of any payment related to POP treatments including transportation.
In this study, low income was significantly associated with delayed POP treatments. This is supported by the study conducted in Gondar, which reported the women with a lack of money were about two times more probably delay POP treatments (AOR = 2, 95% CI 1.01, 3.86) [12]. Women with a shortage of income were not able to afford the health service expenses, transport, food, and other costs [22, 23]. It is a fact that most rural mothers in Ethiopia are not economically empowered [23]. Besides, in our context, women have many responsibilities that should carry out in day-to-day activities but not to generate income, and the power to make the financial decision is not by their hands and these and thus situation doubles their problems [23].
In this study, fear of social stigma increases the likelihood to delay treatments. A study conducted to assess reasons for delayed treatments of POP and fistula patients at the University of Gondar Comprehensive and Specialized Hospital, Ethiopia, reported fearing social stigma was not associated with delay for treatments of POP. However, that study reported women who fear disclosing fistula owing to social stigma were two times more likely to delay the fistula treatments when compared with their counterparts [12]. The possible justification for the discrepancy is most probable Hamlin Fistula Center in Gondar has been delivering integrated service of fistula and POP care, repeatedly conducting the POP campaign and expanding awareness creation about the problem in the Gondar community.
In this study, out of 123 POP patients, 7.3% were divorced due to POP. This is comparable with the report of a study from Uganda that reported their husband rejected about 25% of women with POP [20]. The same was true in Nepal among women with POP [24] and in Gondar among women with fistula [12]. Moreover, qualitative studies in Nepal and Bahr Dar also believe that social stigma is the most important barrier to seek health care and to expose problems even to their close ones feeling it shameful because POP involves the most sensitive part of the body (genitalia) [16, 24]. Furthermore, due to fear of discrimination and rejection from people, they hide the illness at all and they disclose when it gets severe and unbearable after an extended duration of time since they begin to feel symptoms. Because of this delay, the problem reaches its advanced stage, which causes surgical interventions to become the only possible treatment solution. Notably, most women in Southern Ethiopia have less awareness about the POP and unable to reveal their problems related to their genitalia (sensitive body parts) because of the feeling of shamefulness, which has a deep root in the culture of the society.
As a limitation, this study was hospital-based and, hence, lacks generalizability to the community at large. Moreover, further study is needed in different places and the population.

Conclusions

In this study, most of the POP patients were delayed for POP treatments. Factors like lack of support, low income, and fear of losing social value/stigma were associated with the delay in seeking treatment. Screening for the POP cases, educating (making awareness) the community about this devastating disease to facilitate early treatment and to avoid social stigma, and raising access to treatment by making the nearby hospitals equipped with facilities to treat POP are recommended.

Acknowledgements

We would like to pass our deepest gratitude to the College of Medicine and Health Sciences, University of Gondar, for creating such a conducive learning environment, providing financial support, and giving this chance to conduct this project. Moreover, our thanks would be to the hospital directors, data collectors, and study participants for their commitment during data collection.

Declarations

Ethical clearance was obtained from the Ethical Review Committee of the College of Medicine and Health Sciences, University of Gondar. Permission letters were obtained from the SNNPR Health Bureau and the administrations of each hospital. After a brief explanation about the objectives of the study for the participants, written informed consent was obtained from study participants. Furthermore, confidentiality was kept carefully by using codes instead of any personal identifiers, and privacy was maintained given that the standard medical examination/practice has been done. We confirm that all methods were performed in accordance with the relevant guidelines and regulations.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Iglesia CB, Smithling KR. Pelvic organ prolapse. Am Fam Phys. 2017;96(3):179–85. Iglesia CB, Smithling KR. Pelvic organ prolapse. Am Fam Phys. 2017;96(3):179–85.
2.
Zurück zum Zitat Sharma A, Zhang JP. Risk factors and symptoms of uterine prolapse: reality of Nepali women. Asian Women. 2014;30(1):81–95. Sharma A, Zhang JP. Risk factors and symptoms of uterine prolapse: reality of Nepali women. Asian Women. 2014;30(1):81–95.
3.
Zurück zum Zitat Belayneh T, Gebeyehu A, Adefris M, Rortveit G, Awoke T. Pelvic organ prolapse in Northwest Ethiopia: a population-based study. Int Urogynecol J. 2019;31:1873–81.CrossRef Belayneh T, Gebeyehu A, Adefris M, Rortveit G, Awoke T. Pelvic organ prolapse in Northwest Ethiopia: a population-based study. Int Urogynecol J. 2019;31:1873–81.CrossRef
4.
Zurück zum Zitat Horst W, Do Valle JB, Silva JC, Gascho CLL. Pelvic organ prolapse: prevalence and risk factors in a Brazilian population. Int Urogynecol J. 2017;28(8):1165–70.CrossRef Horst W, Do Valle JB, Silva JC, Gascho CLL. Pelvic organ prolapse: prevalence and risk factors in a Brazilian population. Int Urogynecol J. 2017;28(8):1165–70.CrossRef
5.
Zurück zum Zitat Masenga GG, Shayo BC, Rasch V. Prevalence and risk factors for pelvic organ prolapse in Kilimanjaro, Tanzania: a population based study in Tanzanian rural community. PLoS ONE. 2018;13(4):e0195910.CrossRef Masenga GG, Shayo BC, Rasch V. Prevalence and risk factors for pelvic organ prolapse in Kilimanjaro, Tanzania: a population based study in Tanzanian rural community. PLoS ONE. 2018;13(4):e0195910.CrossRef
6.
Zurück zum Zitat Li Z, Xu T, Li Z, Gong J, Liu Q, Zhu L. An epidemiologic study of pelvic organ prolapse in rural Chinese women: a population-based sample in China. Int Urogynecol J. 2019;30(11):1925–32.CrossRef Li Z, Xu T, Li Z, Gong J, Liu Q, Zhu L. An epidemiologic study of pelvic organ prolapse in rural Chinese women: a population-based sample in China. Int Urogynecol J. 2019;30(11):1925–32.CrossRef
7.
Zurück zum Zitat Dheresa M, Worku A, Oljira L, Mengistie B, Assefa N, Berhane Y. Factors associated with pelvic floor disorders in Kersa District, Eastern Ethiopia: a community-based study. Int Urogynecol J. 2019;30(9):1559–64.CrossRef Dheresa M, Worku A, Oljira L, Mengistie B, Assefa N, Berhane Y. Factors associated with pelvic floor disorders in Kersa District, Eastern Ethiopia: a community-based study. Int Urogynecol J. 2019;30(9):1559–64.CrossRef
8.
Zurück zum Zitat Aytan H, Ertunç D, Tok EC, Yaşa O, Nazik H. Prevalence of pelvic organ prolapse and related factors in a general female population. Turk J Obstet Gynecol. 2014;11(3):176.CrossRef Aytan H, Ertunç D, Tok EC, Yaşa O, Nazik H. Prevalence of pelvic organ prolapse and related factors in a general female population. Turk J Obstet Gynecol. 2014;11(3):176.CrossRef
9.
Zurück zum Zitat Gurjar B, Kedar K. Pelvic organ prolapse—a concern. J Evol Med Dent Sci. 2017;6(14):1080–3.CrossRef Gurjar B, Kedar K. Pelvic organ prolapse—a concern. J Evol Med Dent Sci. 2017;6(14):1080–3.CrossRef
10.
Zurück zum Zitat El Kady OSH, Tamara TF, El Mohsen Sabaa HA, Shawky Hafez AHM. Assessment of the prevalence of pelvic floor disorders in both vaginal and cesarean deliveries and their impact on the quality of life. Egypt J Hosp Med. 2017;68(2):1252–6.CrossRef El Kady OSH, Tamara TF, El Mohsen Sabaa HA, Shawky Hafez AHM. Assessment of the prevalence of pelvic floor disorders in both vaginal and cesarean deliveries and their impact on the quality of life. Egypt J Hosp Med. 2017;68(2):1252–6.CrossRef
11.
Zurück zum Zitat Eleje G, Udegbunam O, Ofojebe C, Adichie C. Determinants and management outcomes of pelvic organ prolapse in a low resource setting. Ann Med Health Sci Res. 2014;4(5):796–801.CrossRef Eleje G, Udegbunam O, Ofojebe C, Adichie C. Determinants and management outcomes of pelvic organ prolapse in a low resource setting. Ann Med Health Sci Res. 2014;4(5):796–801.CrossRef
12.
Zurück zum Zitat Adefris M, Abebe SM, Terefe K, Gelagay AA, Adigo A, Amare S, et al. Reasons for delay in decision making and reaching health facility among obstetric fistula and pelvic organ prolapse patients in Gondar University hospital, Northwest Ethiopia. BMC Womens Health. 2017;17(1):64.CrossRef Adefris M, Abebe SM, Terefe K, Gelagay AA, Adigo A, Amare S, et al. Reasons for delay in decision making and reaching health facility among obstetric fistula and pelvic organ prolapse patients in Gondar University hospital, Northwest Ethiopia. BMC Womens Health. 2017;17(1):64.CrossRef
13.
Zurück zum Zitat Akmel M, Segni H. Pelvic organ prolapse in Jimma University Specialized Hospital, Southwest Ethiopia. Ethiop J Health Sci. 2012;22(2):85–92.PubMedPubMedCentral Akmel M, Segni H. Pelvic organ prolapse in Jimma University Specialized Hospital, Southwest Ethiopia. Ethiop J Health Sci. 2012;22(2):85–92.PubMedPubMedCentral
14.
Zurück zum Zitat Hurissa T, Bekele D. A one-year review of pelvic organ prolapse at St. Paul's Hospital Millennium Medical College, Addis Ababa Ethiopia. 2018. Hurissa T, Bekele D. A one-year review of pelvic organ prolapse at St. Paul's Hospital Millennium Medical College, Addis Ababa Ethiopia. 2018.
15.
Zurück zum Zitat Henok A. Prevalence and factors associated with pelvic organ prolapse among pedestrian back-loading women in Bench Maji Zone. Ethiop J Health Sci. 2017;27(3):263–72.CrossRef Henok A. Prevalence and factors associated with pelvic organ prolapse among pedestrian back-loading women in Bench Maji Zone. Ethiop J Health Sci. 2017;27(3):263–72.CrossRef
16.
Zurück zum Zitat Gjerde JL, Rortveit G, Muleta M, Adefris M, Blystad A. Living with pelvic organ prolapse: voices of women from Amhara region, Ethiopia. Int Urogynecol J. 2017;28(3):361–6.CrossRef Gjerde JL, Rortveit G, Muleta M, Adefris M, Blystad A. Living with pelvic organ prolapse: voices of women from Amhara region, Ethiopia. Int Urogynecol J. 2017;28(3):361–6.CrossRef
17.
Zurück zum Zitat Chen G-D, Ng S-C. Updated definition of female pelvic organ prolapse. Incont Pelvic Floor Dysfunct. 2007;1(4):121–4. Chen G-D, Ng S-C. Updated definition of female pelvic organ prolapse. Incont Pelvic Floor Dysfunct. 2007;1(4):121–4.
18.
Zurück zum Zitat Schreiner M. Estimating consumption-based poverty in the Ethiopia Demographic and Health Survey. Ethiop J Econ. 2012;21(1):73–106. Schreiner M. Estimating consumption-based poverty in the Ethiopia Demographic and Health Survey. Ethiop J Econ. 2012;21(1):73–106.
19.
Zurück zum Zitat Adelowo A, O’Neal E, Hota L. Underlying factors contributing to the delay in patients seeking care for pelvic floor dysfunction. Clin Trials J. 2014;4(174):2167. Adelowo A, O’Neal E, Hota L. Underlying factors contributing to the delay in patients seeking care for pelvic floor dysfunction. Clin Trials J. 2014;4(174):2167.
20.
Zurück zum Zitat Krause HG, Natukunda H, Singasi I, Hicks SS, Goh JT. Treatment-seeking behaviour and social status of women with pelvic organ prolapse, 4th-degree obstetric tears, and obstetric fistula in western Uganda. Int Urogynecol J. 2014;25(11):1555–9.CrossRef Krause HG, Natukunda H, Singasi I, Hicks SS, Goh JT. Treatment-seeking behaviour and social status of women with pelvic organ prolapse, 4th-degree obstetric tears, and obstetric fistula in western Uganda. Int Urogynecol J. 2014;25(11):1555–9.CrossRef
21.
Zurück zum Zitat Krissi H, Eitan R, Edward R, Peled Y. Diagnostic delay in secondary care for lower urinary tract and pelvic organ prolapse symptoms in women. Arch Gynecol Obstet. 2012;286(1):115–8.CrossRef Krissi H, Eitan R, Edward R, Peled Y. Diagnostic delay in secondary care for lower urinary tract and pelvic organ prolapse symptoms in women. Arch Gynecol Obstet. 2012;286(1):115–8.CrossRef
22.
Zurück zum Zitat Baker Z, Bellows B, Bach R, Warren C. Barriers to obstetric fistula treatment in low-income countries: a systematic review. Tro Med Int Health. 2017;22(8):938–59.CrossRef Baker Z, Bellows B, Bach R, Warren C. Barriers to obstetric fistula treatment in low-income countries: a systematic review. Tro Med Int Health. 2017;22(8):938–59.CrossRef
23.
Zurück zum Zitat AAE CSA: Ethiopian Demographic Health Survey. In: ICF international. 2011. AAE CSA: Ethiopian Demographic Health Survey. In: ICF international. 2011.
24.
Zurück zum Zitat Shrestha B, Onta S, Choulagai B, Poudyal A, Pahari DP, Uprety A, et al. Women’s experiences and health care-seeking practices in relation to uterine prolapse in a hill district of Nepal. BMC Womens Health. 2014;14(1):20.CrossRef Shrestha B, Onta S, Choulagai B, Poudyal A, Pahari DP, Uprety A, et al. Women’s experiences and health care-seeking practices in relation to uterine prolapse in a hill district of Nepal. BMC Womens Health. 2014;14(1):20.CrossRef
Metadaten
Titel
Factors associated with delay in seeking treatment among women with pelvic organ prolapse at selected general and referral hospitals of Southern Ethiopia, 2020
verfasst von
Asfaw Borsamo
Mohammed Oumer
Yared Asmare
Ayanaw Worku
Publikationsdatum
01.12.2021
Verlag
BioMed Central
Erschienen in
BMC Women's Health / Ausgabe 1/2021
Elektronische ISSN: 1472-6874
DOI
https://doi.org/10.1186/s12905-021-01245-0

Weitere Artikel der Ausgabe 1/2021

BMC Women's Health 1/2021 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.